Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Imagen Biotech

Request full access

Imagen Biotech - Vision in Sight

New York City, United StatesFounded 2011Biotech & Life Sciences

About Imagen Biotech

Imagen Biotech, operating as Imagen Therapeutics, is a contract research organization focused on accelerating oncological drug discovery and development. Founded in 2007 by former AstraZeneca cell biologists Geoff Muckle and Gareth Griffiths, the company leverages its specialized platform to support the cancer research community. Geoff Muckle, the CEO, brings two decades of experience in pharmaceuticals, with a background in commercial and management roles at major companies like GSK, Bayer, and Roche before transitioning into contract research and leading Imagen. The firm's primary offering is a diagnostic tool that assists oncologists in selecting appropriate treatments for patients, thereby improving outcomes.

The company's business model is centered on providing contract research services to biopharma companies. Its platform is designed to expedite the discovery and development programs of its clients. Operating from Manchester and Sci-Tech Daresbury in the UK, Imagen Therapeutics provides a flexible and proficient High Content Screening service, positioning itself as a dedicated High Content Biology company. This service helps scientists enhance their research efficiency and output. The company's work supports the broader trend in medicine towards personalized treatments, which is driving growth in the organoid and 3D cell culture market. This market, essential for more accurate preclinical drug screening, is projected to expand significantly, with some forecasts predicting it will reach over USD 11 billion by 2033.

Imagen Therapeutics' growth trajectory included a move to a new base in the Liverpool city region, backed by a grant from the Liverpool City Region Combined Authority’s Inward Investment Facilitation Fund, with plans to significantly expand its workforce. The company, which was formerly known as Imagen Biotech, has raised a total of $19.8 million in funding to support its operations and expansion efforts.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2011
Headquarters
New York City, United States
Employees
1
Open positions
None listed
Dealroom signal
57.1/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Visualization, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2C

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Oct 2011 $40M $160M SV Health Investors · Novo Ventures · F-Prime —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Imagen Biotech website traffic

Latest recorded traffic for Imagen Biotech is 140 monthly website visits. Imagen Biotech's team grew 0% over the past year.

Latest monthly visits140 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Imagen Biotech in the New York City ecosystem

Live from Dealroom

The Imagen Biotech office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • SV Health Investors
  • Novo Ventures
  • F-Prime
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · New York City HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Imagen Biotech on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Imagen Biotech’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.